If you’re taking a GLP-1 medication, such as semaglutide (Ozempic or Wegovy), exercise is an essential part of your routine — and not just for weight loss reasons. “Exercise helps you maintain muscle ...

Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that loss of sight could be a side effect.

Ozempic, originally for type 2 diabetes, has surged in popularity in North America as a weight-loss solution, sparking a ...

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

Jelly Roll, who recently revealed that he’s lost nearly 200 pounds, shared the overall goal he’s aiming to hit in his weight loss journey.

Novo Nordisk has notched a major legal win against compounding pharmacies that make copies of its diabetes and obesity drug ...

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

Unilever on Friday rejected the claim it tried to oust former Ben & Jerry's chief executive Dave Stever for supporting his ...

STAT is tracking, day by day, what's happened in the words of science and health during the first months of the Trump ...